UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Aquila Biopharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
03839F107
--------------------------------------------------
(CUSIP Number)
December 31, 1998
----------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 13 pages
<PAGE>
CUSIP NO. 03839F107
---------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
I.R.S. Identification No. of above person (entities only)
Marcus Schloss & Co., Inc.
TP # 13-5676531
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
New York
- --------------------------------------------------------------------------------
5. Sole Voting Power
Number of 570,253*
Shares -------------------------------------------------
Beneficially 6. Shared Voting Power
Owned by None
Each -------------------------------------------------
Reporting 7. Sole Dispositive Power
Person 570,253*
With: -------------------------------------------------
8. Shared Dispositive Power
None
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting
Person
570,253*
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
[ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
8.2%
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
BD
- --------------------------------------------------------------------------------
Page 2 of 13 pages
<PAGE>
CUSIP NO. 03839F107
---------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
I.R.S. Identification No. of above person (entities only)
Douglas Schloss
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U.S.A.
- --------------------------------------------------------------------------------
5. Sole Voting Power
Number of 642,253*
Shares -------------------------------------------------
Beneficially 6. Shared Voting Power
Owned by None
Each -------------------------------------------------
Reporting 7. Sole Dispositive Power
Person 642,253*
With: -------------------------------------------------
8. Shared Dispositive Power
None
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting
Person
642,253*
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
[ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
9.2%
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IN
- --------------------------------------------------------------------------------
Page 3 of 13 pages
<PAGE>
CUSIP NO. 03839F107
---------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
I.R.S. Identification No. of above person (entities only)
Richard Perry Schloss
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U.S.A.
- --------------------------------------------------------------------------------
5. Sole Voting Power
Number of 642,253*
Shares -------------------------------------------------
Beneficially 6. Shared Voting Power
Owned by None
Each -------------------------------------------------
Reporting 7. Sole Dispositive Power
Person 642,253*
With: -------------------------------------------------
8. Shared Dispositive Power
None
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting
Person
642,253*
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
[ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
9.2%
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IN
- --------------------------------------------------------------------------------
Page 4 of 13 pages
<PAGE>
* Each of Douglas Schloss and Richard P. Schloss may be deemed to control
Marcus Schloss & Co., Inc. ("Marcus Schloss") and thus each of Douglas
Schloss, Richard P. Schloss and Marcus Schloss may be considered to have
beneficial ownership of, and voting and dispositive power over, the 570,253
shares of Common Stock, par value $.01 per share ("Common Stock"), of
Aquila Biopharmaceuticals, Inc. beneficially owned by Marcus Schloss. In
addition, each of Douglas Schloss and Richard P. Schloss may be deemed to
control two private investment funds (the "Funds") which, in the aggregate,
beneficially own 72,000 shares of Common Stock. Accordingly, each of
Douglas Schloss and Richard P. Schloss may be considered to have beneficial
ownership of, and voting and dispositive power over, the aggregate of
642,253 shares of Common Stock beneficially owned by Marcus Schloss and the
Funds.
All information regarding Common Stock ownership in this Amendment No. 2 to
Schedule 13G is provided as of December 31, 1998.
Page 5 of 13 pages
<PAGE>
The Statement on Schedule 13G, dated February 11, 1998, as amended by
Amendment No. 1 thereto, dated May 8, 1998, of Marcus Schloss & Co., Inc.,
Douglas Schloss and Richard P. Schloss relating to shares of Common Stock, $.01
par value, of Aquila Biopharmaceuticals, Inc., a Delaware corporation, is hereby
amended to insert the following information in response to the items indicated.
Item 1(a). Name of Issuer
--------------
Aquila Biopharmaceuticals, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices
-----------------------------------------------
175 Crossing Boulevard
Framingham, Massachusetts 01702
Item 2(a). Names of Persons Filing
-----------------------
Marcus Schloss & Co., Inc. ("Marcus Schloss"), Douglas Schloss and
Richard P. Schloss. Each of Douglas Schloss and Richard P. Schloss may be deemed
to control Marcus Schloss.
Item 2(b). Address of Principal Business Office
------------------------------------
One Whitehall Street
New York, New York 10004
Item 2(c). Citizenship
-----------
Marcus Schloss is a New York corporation. Douglas Schloss and
Richard P. Schloss are United States citizens.
Item 2(d). Title of Class of Securities
----------------------------
Common Stock
Item 2(e). CUSIP Number
------------
03839F107
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.SS. 240.13d-1(b) OR
240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
----------------------------------------------------------
(a) [X]* Broker or dealer registered under Section 15 of the
Act (15 U.S.C. 780);
(b) [ ] Bank as defined in Section 3(a)(6) of the Act (15
U.S.C. 78c);
Page 6 of 13 pages
<PAGE>
(c) [ ] Insurance company as defined in Section 3(a)(19)of the
Act (15 U.S.C. 78c);
(d) [ ] Investment company registered under Section 8 of the
Investment Company Act (15 U.S.C. 80a-8);
(e) [ ] An investment adviser in accordance with ss.
240.13d-1(b)(l)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in
accordance with ss. 240.13d- 1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in
accordance with ss. 240.13d- 1(b)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of
an investment company under Section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with ss. 240.13d- 1(b)(1)(ii)(J).
- ------------------------
* Marcus Schloss is a registered broker-dealer. Douglas Schloss and Richard
P. Schloss are control persons of Marcus Schloss but are not eligible to
file this Schedule 13G under Rule 13d-1(b)(ii)(G) as (i) they may be deemed
to control the Funds (as defined in Item 4 below), (ii) the Funds in the
aggregate beneficially own more than 1% of the outstanding Common Stock,
and (iii) the Funds are not persons specified in Rule 13d- 1(b)(1)(ii)(A)
through (I).
Item 4. Ownership
I. Marcus Schloss & Co., Inc.
--------------------------
(a) Amount Beneficially Owned: 570,253 shares
(b) Percent of Class: 8.2%
Page 7 of 13 pages
<PAGE>
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 570,253
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
570,253
(iv) shared power to dispose or to direct the disposition of:
None
II. Douglas Schloss
---------------
(a) Amount Beneficially Owned: 642,253 shares
(b) Percent of Class: 9.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 642,253
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
642,253
(iv) shared power to dispose or to direct the disposition of:
None
III. Richard P. Schloss
------------------
(a) Amount Beneficially Owned: 642,253 shares
(b) Percent of Class: 9.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 642,253
Page 8 of 13 pages
<PAGE>
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
642,253
(iv) shared power to dispose or to direct the disposition of:
None
Marcus Schloss beneficially owns 570,253 shares of Common Stock and
has the sole power to vote and the sole power to dispose of all such shares.
Each of Douglas Schloss and Richard P. Schloss may be deemed to control each of
(i) Marcus Schloss, and (ii) two private investment funds (the "Funds") which,
in the aggregate, beneficially own 72,000 shares of Common Stock. Accordingly,
each of Douglas Schloss and Richard P. Schloss may be considered to have
beneficial ownership of the aggregate of 642,253 shares of Common Stock
beneficially owned by Marcus Schloss and the Funds.
Alison Schloss, the spouse of Douglas Schloss, is the trustee of two
trusts which, in the aggregate, beneficially own 3,478 shares of Common Stock.
The beneficiaries of such trusts are the children of Alison Schloss and Douglas
Schloss. Douglas Schloss disclaims beneficial ownership of all such shares of
Common Stock owned by such trusts.
Item 5. Ownership of Five Percent or Less of a Class
--------------------------------------------
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of
Another Person
------------------------------------------------
As described in the footnote to the cover pages and in response to
Item 4 above, each of Douglas Schloss and Richard P. Schloss may be deemed to
control the Funds which, in the aggregate, beneficially own 72,000 shares of
Common Stock. Each Fund is entitled to the full economic benefits of all shares
of Common Stock owned by it.
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company
--------------------------------------------
Not applicable.
Item 8. Identification and Classification of Members of
the Group
-----------------------------------------------
Not applicable.
Page 9 of 13 pages
<PAGE>
Item 9. Notice of Dissolution of Group
------------------------------
Not applicable.
Item 10. Certification
-------------
By signing below each of the undersigned certifies that, to the best
of its or his knowledge and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction
having that purpose or effect.
DISCLAIMER
- ----------
Each of Douglas Schloss and Richard P. Schloss hereby declares that
the filing of this Amendment No. 2 to Schedule 13G shall not be construed as an
admission that he is, for the purposes of Section 13(d) or 13(g) of the
Securities Exchange Act of 1934, the beneficial owner of any securities covered
herein.
Page 10 of 13 pages
<PAGE>
SIGNATURES
After reasonable inquiry and to the best knowledge and belief of
each, the undersigned certify that the information set forth in this statement
is true, complete and correct.
Date: February 11, 1999
MARCUS SCHLOSS & CO., INC.
By: /s/ Douglas Schloss
--------------------------------
Douglas Schloss
Chairman
DOUGLAS SCHLOSS
/s/ Douglas Schloss
--------------------------------
Douglas Schloss
RICHARD P. SCHLOSS
/s/ Richard P. Schloss
--------------------------------
Richard P. Schloss
Page 11 of 13 pages
<PAGE>
EXHIBIT INDEX
Page
----
Exhibit A Joint Filing Agreement 13
Page 12 of 13 pages
Exhibit A
---------
JOINT FILING AGREEMENT
----------------------
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act
of 1934, as amended, the undersigned hereby agree to the joint filing on behalf
of each of them of a statement on Schedule 13G (including amendments thereto)
with respect to the Common Stock of Aquila Biopharmaceuticals, Inc., and that
this Agreement be included as an Exhibit to such joint filing. This Agreement
may be executed in counterparts all of which taken together shall constitute one
and the same instrument.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this
11th day of February, 1999.
/s/ Douglas Schloss
--------------------------------
Douglas Schloss
/s/ Richard P. Schloss
--------------------------------
Richard P. Schloss
MARCUS SCHLOSS & CO., INC.
By: /s/ Douglas Schloss
----------------------------
Douglas Schloss
Chairman
Page 13 of 13 pages
